Atropisomerism - A Neglected Way to Escape Out of Solubility Flatlands.

J Pharm Sci

Merck KGaA, Global Medicinal Chemistry, Frankfurter Strasse 250, 64293 Darmstadt, Germany.

Published: January 2022

Low solubility of drugs represents a major challenge during research and development. Ways to overcome this are either focused on formulation development or optimization of the molecular structure of the drug. The latter is not only governed by the constitution of the molecule but also by its stereochemistry. Development of enantiomers in contrast to racemic mixtures has become the state of the art over the last decades as this leads to higher potency and selectivity. Thus, enantiopure drugs require lower doses compared to their racemates. Additionally, selecting one enantiomer also leads to improved solubility of the drug compared to its racemic compound. While this effect is well known for enantiomers and racemic compounds where chirality is introduced via a chiral central atom, here we describe the first case where improved solubility is realized by selecting an axially chiral atropisomer.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.xphs.2021.10.011DOI Listing

Publication Analysis

Top Keywords

improved solubility
8
atropisomerism neglected
4
neglected escape
4
solubility
4
escape solubility
4
solubility flatlands
4
flatlands low
4
low solubility
4
solubility drugs
4
drugs represents
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!